According to our latest market research study on “US and Europe Surrogacy Market Forecast to 2030  – COVID-19 Impact and Regional Analysis – by Type, Age Group, and Service Order,” the US and Europe Surrogacy market is expected to reach US$ 25,284.02 million by 2030  from US$ 6,113.72 million in 2022; it is estimated to record a CAGR of 19.4% from 2022 to 2030.

The report highlights trends prevailing in the market, along with market drivers and deterrents. The key factors that are driving the growth of the market includes increase in infertility cases and increase in number of fertility clinics. However, high cost of surrogacy treatment procedure is likely to act as restraining factors for the surrogacy market.                 

Infertility is becoming a more common condition, mainly because many couples wait long to have children later in life. Some doctors and researchers also believe that it is becoming an epidemic. According to the Centers for Disease Control and Prevention (CDC), infertility affects roughly 1 in 5 married women of age 15–49 who have never given birth. ~6% of married women aged 15–49 years are incapable of becoming pregnant after one year of trying, and 14% have difficulty getting pregnant or carrying a pregnancy to term. Further, there has been an overall long-term decline in birth and fertility rates in the US owing to factors such as advanced education and career opportunities for women, improved access to contraception, delayed childbearing after marriage, and preference for reduced family size. An increasing number of infertility cases in the US and Europe is providing a major impetus to the surrogacy market growth. Surrogacy, which involves a woman carrying a pregnancy for another individual or couple, has become an alternative solution for those facing infertility challenges. Further, a rapid increase in the number of surrogacy clinics and hospitals in the US and Europe would increase access to fertility treatments, thereby creating growth prospects within the market.

The increasing cases of infertility, an emerging trend of late pregnancies among women, and a rise in the rate of gamete donations are the key factors contributing to the surrogacy market growth in the US. Additionally, the availability of fertility treatments, increased awareness about infertility, an upsurge in disposable income, and the enactment of favorable reimbursement policies further drive the surrogacy market growth in the US. Stringent surrogacy legislation due to the "Baby M" case in 1986 prompted many surrogacy service providers to adopt gestational practices to avoid legal penalties. However, as the demand remained steady, these laws had little impact on the growth of the surrogacy industry. The subsequent expansion of fertility and surrogacy clinics, and a rise in same-sex marriages are anticipated to create attractive growth possibilities for the surrogacy market in the US.

The US has a well-established infrastructure and support system for surrogacy arrangements. There are various surrogacy agencies, fertility clinics, and legal professionals specializing in reproductive law that assist intended parents throughout the surrogacy process. These professionals help facilitate matching intended parents with suitable surrogates, coordinate medical procedures, and navigate legal complexities. In addition, financial aspects also play a role in the growth of the US surrogacy market. While the costs associated with surrogacy can vary significantly, clinics in the US offer a range of options catering to different budget scenarios. According to American Fertility Services (AFS), surrogacy costs in the US range from US$ 60,000 to US$ 150,000; the total costs may vary in every case. Further, the availability of insurance coverage for surrogacy-related medical expenses and competitive pricing structures benefits the surrogacy industry in the US.

The US and Europe Surrogacy market, based on technology, is segmented into intrauterine insemination (IUI) and in-vitro fertilization (IVF). In 2022, the IVF segment held the largest share of the market, and the same segment is expected to grow at the fastest rate during the coming years. In-vitro fertilization (IVF) is a process in which the egg is fertilized in a laboratory environment, and after fertilization, the embryo is transferred to the uterus of a surrogate mother. Generally, multiple embryos are transferred to the uterus, which increases the chances of multiple pregnancies. IVF has a higher success rate as compared to IUI, as the embryo is directly transferred to the uterus. In the case of IVF technology, genetic testing of the embryo can be done, which can help identify genetic disorders before implantation. Moreover, embryos can be frozen after fertilization if the intended parents want delayed conception; frozen embryos can also be used upon the failure of previous IVF cycles. IVF can be performed via two techniques: classical/standard IVF and intracytoplasmic sperm injection (ICSI).

London Women's Clinic Ltd, The Centre for Reproductive and Genetic Health Ltd, Miracle Baby Surrogacy, Lotus Surrogacy, VittoriaVita LLC, Sensible Surrogacy, New Life Ukraine, Redia Ltd, Circle Surrogacy LLC, and Ovation Fertilityare among the leading companies operating in the US and Europe surrogacy market.

The report segments the US and Europe Surrogacy market as follows:

Based on offering, the US and Europe surrogacy market is segmented into type, technology, age group and service orders. By type, is segment into Gestational Surrogacy and Traditional Surrogacy. Based on age group, the US and Europe surrogacy market is segmented into Below 35 years, 35-37 years, 38 - 39 years, 40-42 years, 43-44 years, and Over 44 years. Based on technology, the US and Europe surrogacy market is classified into Intrauterine Insemination and In-vitro Fertilization. By service order market for US and Europe surrogacy segmented into Hospitals, Fertility Clinics, and Others. Furthermore, By geography, the US and Europe surrogacy Market is segmented into US and Europe (Italy, UK, Denmark, The Netherlands, Irelands, and Rest of Europe).

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com